Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
QURE
#2407
uniQure N.V.
17.4
7
USD
+2.22%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.22%
Monthly Change
+11.92%
6 month change
-72.26%
Year Change
+83.89%
Previous Close
17.0
9
Open
17.3
0
Bid
Ask
Low
17.2
5
High
17.5
5
Volume
72
Markets
US Stock Market
Healthcare
QURE
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
44.99 M
46.46 M
46.98 M
47.84 M
54.08 M
62.53 M
—
Valuation ratios
Enterprise value
1.42 B
508.22 M
900.88 M
191.91 M
847.39 M
1.47 B
5.53 B
Price to earnings ratio
—
2.95
-8.06
-1.07
-3.59
-6.92
-26.23
Price to sales ratio
—
1.85
9.59
20.85
31.68
85.48
358.14
Price to cash flow ratio
—
3.37
-7.04
-2.26
-4.7
-7.73
-34.97
Price to book ratio
—
1.63
2.14
1.59
-127.24
6.92
32.2
Enterprise value to EBITDA ratio
-11.93
1.78
-6.66
-0.79
-4.57
-7.66
-28.98
Profitability ratios
Return on assets %
-0.37
0.41
-0.18
-0.37
-0.43
-0.24
-0.27
Return on equity %
-0.51
0.55
-0.27
-1.49
35.48
-1
7.59
Return on invested capital %
-537.78
796.56
-212.61
-432.13
-385.63
-429.58
-401.2
Gross margin %
92.27
95.23
98.82
99.59
95.33
89.53
356.4
Operating margin %
-334.34
59.28
-134.44
-1 785.46
-679.58
-1 151.38
-5 640.59
EBITDA margin %
-324.59
58.26
-132.71
-1 816.93
-694.89
-1 199.4
-6 346.2
Net margin %
-333.27
62.9
-119.07
-1 947.09
-883.35
-1 236
-6 343.49
Liquidity ratios
Quick ratio
—
—
6.19
8.68
—
—
—
Current ratio
9.47
17.09
6.28
8.85
9.74
10.43
39.52
Inventory turnover
—
—
0.18
0.01
—
—
—
Asset turnover
0.1
0.91
0.14
0.02
0.04
0.02
0.02
Solvency ratios
Debt to assets ratio
0.1
0.12
0.15
0.12
0.09
0.06
0.29
Debt to equity ratio
0.15
0.17
0.22
0.49
-7.6
0.25
-10.94
Long term debt to total assets ratio
0.1
0.12
0.15
0.12
0.09
0.06
0.29
Long term debt to total equity ratio
0.15
0.17
0.22
0.49
-7.6
0.25
-10.94
Per share metrics
Operating cash flow per share
—
6.15
-3.1
-3.06
-3.76
-3.09
-3.19
EBIT per share
—
6.39
-3.2
-6.03
-3.86
-3.33
-3.42
EBITDA per share
—
6.52
-3.02
-6.04
-3.87
-3.36
-3.61
Total debt per share
—
2.16
2.2
2.13
1.05
0.86
3.67
Cash per share
—
11.88
7.55
12.96
7.56
10.83
37.28
Net current asset value per share
—
13.41
10.2
13.67
8.02
11.41
39.3
Tangible book value per share
—
10.79
8.38
2.53
-2.06
1.75
0.89
Working capital per share
—
12.63
8.58
12.13
7.2
10.31
35.06
Book value per share
—
12.72
10.19
4.36
-0.14
3.46
7.93
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
News
Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?
uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com
Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
A Unique Situation For UniQure (QURE)
Mizuho upgrades uniQure stock rating on FDA leadership change
Avago, Lumentum among market cap stock movers on Monday
Chardan raises uniQure stock price target on FDA leadership change
Tesla and Facebook among market cap stock movers on Monday
Biotech Stocks Pop After CBER Chief Exit - Moderna (NASDAQ:MRNA)
This biotech’s stock is soaring after a ‘polarizing’ FDA official is stepping down
Truist sees positive reaction for biotech stocks after FDA official exit